adlitterio66339

13 06, 2022

Monica Niger et al., MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers.

adlitterio663392022-10-20T12:13:30+02:00

Read More

9 06, 2022

Jana Fassunke et al., Biomarker testing in lung cancer patients- upscaling the fast track analysis

adlitterio663392022-10-14T11:08:32+02:00

Read More

7 06, 2022

Federica Petrelli et al., Peripancreatic paraganglioma: Lesson from a round table

adlitterio663392022-10-13T16:09:58+02:00

Read More

1 06, 2022

Gian Franco Zannoni et al., Biomarker characterization in endometrial cancer in Italy: first survey data analysis

adlitterio663392022-10-20T12:08:07+02:00

Read More

1 06, 2022

Gian Franco Zannoni et al., Biomarker characterization in endometrial cancer in Italy: first survey data analysis

adlitterio663392022-10-14T11:29:19+02:00

Read More

19 05, 2022

Ria Winkelmann et al., MSI status and p53 expression in benign and malignant salivary gland neoplasms

adlitterio663392022-10-20T12:19:24+02:00

Read More

13 05, 2022

Mario Caccese et al., Definition of the Prognostic Role of MGMT Promoter Methylation Value by Pyrosequencing in Newly Diagnosed IDH Wild-Type Glioblastoma Patients Treated with Radiochemotherapy: A Large Multicenter Study

adlitterio663392022-10-20T12:16:20+02:00

Read More

6 05, 2022

Cristina Morelli et al., Concordance of Blood-Based and Normal Tissue-Based Dihydropyrimidine Dehydrogenase (DPYD) Genotyping

adlitterio663392022-10-14T11:46:30+02:00

Read More

1 05, 2022

Mario Rizzato et al., Prognostic impact of FGFR2/3 alterations in patients with biliary tract cancers receiving systemic chemotherapy: the BITCOIN study

adlitterio663392022-10-20T13:47:15+02:00

Read More

27 04, 2022

Bruno Perotti et al., Comparison of Survival Analysis After Surgery for Colorectal Cancer in Above 80 Years (Oldest-Old) and Below 80 Years Old Patients

adlitterio663392022-10-13T16:16:14+02:00

Read More